B
INSP icon

Bailard’s Inspire Medical Systems INSP Stock Holding History

Bailard’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,293
Closed -$257K – 764
2023
Q3 		$257K Hold
1,293
– – 0.01% 583
2023
Q2 		$420K Buy
+1,293
New +$369K 0.01% 438

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bailard's INSP Position: Q4 2023 in Review

Bailard sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 1,293 shares — an estimated $257K sold.

Bailard first reported a position in INSP in Q2 2023 and held it in 2 quarters. The position peaked at $420K in Q2 2023. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

  • Bailard reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
  • Bailard sold 1,293 Inspire Medical Systems shares in Q4 2023, an estimated $257K.
  • Bailard first reported a position in Inspire Medical Systems in Q2 2023 and held it in 2 quarters.
  • Bailard's Inspire Medical Systems position peaked at $420K in Q2 2023.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Bailard's 13F filing for Q4 2023, filed 2 Feb 2024.